In addition to the MRD oral abstract, additional research highlights include: “We have an exciting, diverse, and sizable slate of oncology results being presented at ASCO this year, where each ...

Biosimilars offer high-quality, lower-cost cancer treatments. Learn how they’re helping patients and reshaping global ...

Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The Royal Marsden NHS Foundation Trust, a specialist cancer center, has announced a pioneering partnership with NTT Data and CARPL.ai, a enterprise imaging artificial intelligence (AI) and machine ...

M42 and Cleveland Clinic Abu Dhabi, have signed a Memorandum of Cooperation (MoC) with Gunma University in Japan to accelerate research and innovation in heavy ion therapy, one of the most advanced ...

Developed over five phases, BioMed Realty’s Gateway of Pacific campus consists of 2.2 million square feet of state-of-the-art ...

“Our accelerated pace of innovation demonstrates that we offer more impact, together, in our mission toward a world without fear of cancer.” Varian and Siemens Healthineers will announce ...

Dr Petros Grivas previews data from the AMPLITUDE trial, IRONMAN registry, genomic testing trends, emerging bispecific antibodies, and advances in radioligand therapy.

The firm presented data at AACR that showed the test had high accuracy when distinguishing ovarian cancer at early stages.